Meningococcal Groups A, B, C, W and Y Vaccine (PENMENVY)
Meningococcal Groups A, B, C, W and Y Vaccine is an FDA-licensed reference biologic from GlaxoSmithKline Biologicals. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2025
Reference approved
Reference product
PENMENVY Meningococcal Groups A, B, C, W and Y Vaccine
GlaxoSmithKline Biologicals
- Approved
- Feb 14, 2025
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Meningococcal Groups A, B, C, W and Y Vaccine, in chronological order.
Reference approval
Approval date of the reference Meningococcal Groups A, B, C, W and Y Vaccine product.
1 yr 4 mo ago
Frequently asked questions
Are there biosimilars approved for Meningococcal Groups A, B, C, W and Y Vaccine (PENMENVY)?
No 351(k) biosimilars or interchangeable biosimilars referencing Meningococcal Groups A, B, C, W and Y Vaccine are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.